ArticleFrontiers in cardiovascular medicine2022

Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 diabetes: A population-based cohort study.

Tsung-Kun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.